Meng Zhou

Prof. Meng Zhou


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2021 in Asian Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
HZHong Zhang
Hong Zhang
RZRong‐Hong Zhang
Rong‐Hong Zhang
LWLi‐Xia Wang
Li‐Xia Wang
YLYong‐Jun Li
Yong‐Jun Li
SLShang‐Gao Liao
Shang‐Gao Liao
MZMeng Zhou
Meng Zhou

1 October 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SWShan Wang
Shan Wang
RZRong-Hong Zhang
Rong-Hong Zhang
HZHong Zhang
Hong Zhang
YWYu-Chan Wang
Yu-Chan Wang
DYDan Yang
Dan Yang
MZMeng Zhou
Meng Zhou

16 June 2021 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HZHong Zhang
Hong Zhang
RZRong-Hong Zhang
Rong-Hong Zhang
XLXiang-Ming Liao
Xiang-Ming Liao
DYDan Yang
Dan Yang
YWYu-Chan Wang
Yu-Chan Wang
MZMeng Zhou
Meng Zhou

30 May 2022 in Molecules
Verified
Journal Article
Open access
PDF file
HGHuanyu Guan
Huanyu Guan
PLPengfei Li
Pengfei Li
QWQian Wang
Qian Wang
FZFanli Zeng
Fanli Zeng
DWDaoping Wang
Daoping Wang
WPWeidong Pan
Weidong Pan
Polygonum capitatum as an ethnic medicine has been used to treat urinary tract infections, pyelonephritis and urinary calculi. In our previous study, P. capitatum was found to have anti-hyperuricemia effects. Nevertheless, the active constituents of P. capitatum for treating hyperuricemia were still unclear. In this study, an ultra-high-performance liquid chromatography coupled to quadrupole/orbitrap high-resolution mass spectrometry (UHPLC-Q-Orbitrap HRMS) was used to comprehensively detect the chemical ingredients of P. capitatum and its absorbed constituents in the plasma of hyperuricemia rats for the first time. Xcalibur 3.0 and Compound Discoverer 2.0 software coupled to mzCloud and ChemSpider databases were utilized for qualitative analysis. A total of 114 chemical components including phenolics, flavonoids, tannins, phenylpropanoids, amino acids, amides and others were identified or tentatively characterized based on the exact mass, retention time and structural information. Compared to the previous P. capitatum study, an additional 66 different components were detected. Moreover, 68 related xenobiotics including 16 prototype components and 52 metabolites were found in the plasma of hyperuricemia rats. The metabolic pathways included ring fission, hydrolysis, decarboxylation, dehydroxylation, methylation, glucuronidation and sulfation. This work may provide important information for further investigation on the active constituents of P. capitatum and their action mechanisms for anti-hyperuricemia effects.

16 July 2018 in RSC Advances
Verified
Journal Article
Open access
PDF file
YZYong-Long Zhao
Yong-Long Zhao
YTYong-Qin Tang
Yong-Qin Tang
XFXing-Hai Fei
Xing-Hai Fei
TXTao Xiao
Tao Xiao
YLYa-Dong Lu
Ya-Dong Lu
YYYuan-Yong Yang
Yuan-Yong Yang
A novel and efficient method for the synthesis of nucleophilic 2-monoarylated indole-3-ones via palladium-catalyzed direct C(sp3)–H arylation of indole-3-ones with aryl halides has been developed.

23 June 2022 in Molecules
Verified
Journal Article
Open access
PDF file
YWYu-Chan Wang
Yu-Chan Wang
RZRong-Hong Zhang
Rong-Hong Zhang
SHShengcao Hu
Shengcao Hu
HZHong Zhang
Hong Zhang
DYDan Yang
Dan Yang
MZMeng Zhou
Meng Zhou
As a typical dibenzylisoquinoline alkaloid, tetrandrine (TET) is clinically used for the treatment of silicosis, inflammatory pulmonary, and cardiovascular diseases in China. Recent investigations have demonstrated the outstanding anticancer activity of this structure, but its poor aqueous solubility severely restricts its further development. Herein, a series of its 14-N-amino acid-substituted derivatives with improved anticancer effects and aqueous solubility were designed and synthesized. Among them, compound 16 displayed the best antiproliferative activity against human colorectal cancer (HCT-15) cells, with an IC50 value of 0.57 μM. Compared with TET, 16 was markedly improved in terms of aqueous solubility (by 5-fold). Compound 16 significantly suppressed the colony formation, migration, and invasion of HCT-15 cells in a concentration-dependent manner, with it being more potent in this respect than TET. Additionally, compound 16 markedly impaired the morphology and motility of HCT-15 cells and induced the death of colorectal cancer cells in double-staining and flow cytometry assays. Western blot results revealed that 16 could induce the autophagy of HCT-15 cells by significantly decreasing the content of p62/SQSTM1 and enhancing the Beclin-1 level and the ratio of LC3-II to LC3-I. Further study showed that 16 effectively inhibited the proliferation, migration, and tube formation of umbilical vein endothelial cells, manifesting in a potent anti-angiogenesis effect. Overall, these results revealed the potential of 16 as a promising candidate for further preclinical studies.